1. Home
  2. VVR vs EBS Comparison

VVR vs EBS Comparison

Compare VVR & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Invesco Senior Income Trust (DE)

VVR

Invesco Senior Income Trust (DE)

N/A

Current Price

$2.95

Market Cap

464.9M

Sector

Finance

ML Signal

N/A

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$5.09

Market Cap

413.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVR
EBS
Founded
N/A
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
464.9M
413.3M
IPO Year
1998
2006

Fundamental Metrics

Financial Performance
Metric
VVR
EBS
Price
$2.95
$5.09
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
534.5K
1.3M
Earning Date
01-01-0001
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.83
EPS
N/A
N/A
Revenue
N/A
$742,900,000.00
Revenue This Year
N/A
$1.29
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.93
$4.36
52 Week High
$3.66
$14.06

Technical Indicators

Market Signals
Indicator
VVR
EBS
Relative Strength Index (RSI) 43.34 34.67
Support Level N/A $4.36
Resistance Level $3.01 $8.73
Average True Range (ATR) 0.02 0.33
MACD -0.00 0.01
Stochastic Oscillator 16.67 21.11

Price Performance

Historical Comparison
VVR
EBS

About VVR Invesco Senior Income Trust (DE)

Invesco Senior Income Trust is a diversified, closed-end management investment company. The investment objective is to provide a high level of current income, consistent with preservation of capital. The Trust seeks to achieve its objectives by investing in a portfolio of interests in floating or variable senior loans to corporations, partnerships, and other entities which operate in a variety of industries and geographic regions. The Trust borrows money for investment purposes, which may create the opportunity for enhanced return, but also should be considered a speculative technique and may increase the Trust's volatility.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: